Needham & Company Maintains a 'Strong Buy' on Par Pharmaceutical (PRX); Confirms Purchase of Divested Teva-Cephalon Products for Bargain Price
Go back to Needham & Company Maintains a 'Strong Buy' on Par Pharmaceutical (PRX); Confirms Purchase of Divested Teva-Cephalon Products for Bargain Price| Par Pharmaceutical Cos., Inc. (NYSE: PRX) | Delayed: 49.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.98 | 52 Week High | $52.33 | |||
| Open | $0.02 | 52 Week Low | $26.57 | |||
| Day High | $49.98 | P/E | 24.26 | |||
| Day Low | $49.98 | EPS | $2.06 | |||
| Volume | 7,000 | |||||
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 36.77 +0.25 (0.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.52 | 52 Week High | $66.55 | |||
| Open | $36.26 | 52 Week Low | $37.82 | |||
| Day High | $36.81 | P/E | N/A | |||
| Day Low | $36.09 | EPS | $0.00 | |||
| Volume | 2,332,461 | |||||
